Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1590 results found

2025 ∙ Zhang, Q. Lewis, K. B. Phillips, J. C. Ma, H. Kiss, A. Goge, S. Rader, T. Stacey, D.

Decisional needs of older adults considering COVID-19 booster vaccinations: A systematic review comparing China with other countries

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Blukacz, A. Obach, A. Vasquez, P. Campana, C. Huerta, C. Bernal, Y. Cabieses, B.

Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis

  • All age groups
  • Low and Middle Income Countries
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Bachmann, M. Gultekin, N. Stanga, Z. Fehr, J. S. Ulgur, I. I. Schlagenhauf, P.

Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Sorrentino, M. Fiorilla, C. Rubba, F. Montuori, P. Palladino, R.

Does COVID-19 vaccination affect risk perception and adherence to preventive behaviors? A systematic review and meta-analysis

  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Moore, M. Anderson, L. Schiffer, J. T. Matrajt, L. Dimitrov, D.

Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Cao, B. K. Hanifa, R. S. Nguyen, T. P. Postma, M. J. van der Schans, J.

Economic evaluations of vaccines against respiratory infections in adults in Southeast Asia: A systematic review

  • South-East Asia
  • Western Pacific
  • Adults
  • Older adults
  • Influenza
  • COVID-19
  • Pneumococcal disease
  • Varicella
  • Pertussis
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Phiri, W. W. Kazonga, E. Lubemba, F. Kangwa, G. M. Sakala, L. Banda, M.

Effectiveness of Community-Based Interventions in Reducing Vaccine Hesitancy and Improving COVID-19 Vaccinations Coverage in Developing Countries: A Systematic Review

  • Adults
  • Older adults
  • Low and Middle Income Countries
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Peine, C. Stoliaroff-Pepin, A. Reinacher, U. Heldt, K. Sarganas, G. Piechotta, V. Mikolajewska, A. Pilic, A. Barkowski, N. Bleve, D. Giebeler, M. H. Poser, S. Searle, L. Kissner, E. Nitsche, L. Bayram, F. Siemens, W. Ziegler, A. Meerpohl, J. J. Sandmann, F. Wichmann, O. Harder, T.

Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024

  • Europe
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ma, H. Chen, Y. Y. Shih, W. L. Chen, Y. C. Chen, T. J. Fang, C. T.

Effectiveness of the monovalent XBB.1.5 COVID-19 vaccines: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...